MDXG
MiMedx Group, Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
MiMedx Group (MDXG) Stock: Buy, Sell, or Hold?
$3.32
-0.05 (-1.48%)
▼
5d:
+3.75%
30d:
-29.21%
90d:
-20.95%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (91%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$3.71 – $4.73
Position: OVERSOLD
Forward P/E & Valuation
31.1x
FAIR
vs 27.2x historical avg
Wall Street Target
$7.00
+110.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.05 / $4.02
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: MDXG is fairly valued with market pricing in 4.5% annual growth. Fine to hold or accumulate slowly on dips.
Get Alerted When MDXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MDXG is currently trading at $3.32, which is considered oversold relative to its 30-day fair value range of $3.71 to $4.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 31.1) compared to its historical average (27.2). At these levels, the market is pricing in 4.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MDXG is showing sideways momentum. Immediate support is located at $3.05, while resistance sits at $4.01.
Market Sentiment: MDXG scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+110.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MDXG is showing sideways momentum. Immediate support is located at $3.05, while resistance sits at $4.01.
Market Sentiment: MDXG scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+110.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.71 -
$4.73
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.4%
Trading Range & Key Levels
30-Day Trading Range
$3.71 -
$4.73
Current vs Trading Range
OVERSOLD
Support Level
$3.05
Resistance Level
$4.02
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 110.8% below Wall St target ($7.00)
- NEUTRAL: Market pricing in 4.5% annual earnings growth - fairly valued
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
31.12
Wall Street Target
$7.00
(+110.8%)
Revenue Growth (YoY)
-45.2%
Earnings Growth (YoY)
99.5%
Profit Margin
-6.3%
Valuation Premium vs History
+4.5% premium
PE vs Historical
31.1 vs 27.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.5%
(market-implied from PE analysis)
1-Year Target
$3.47
(+5%)
2-Year Target
$3.63
(+9%)
3-Year Target
$3.79
(+14%)
3-Yr Target (if PE normalizes)
(PE: 31→27)
PE COMPRESSION
$3.31
(0%)
Earnings growth offset by PE compression
Share MDXG Analysis
Share this live MDXG analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MDXG)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Cannacord analyst Doug Rice reaffirmed his belief in the acquisition of $MDXG being on track.
Key Retail Themes:
Acquisition
Company Progress
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:07 AM ET
Data refreshes hourly during market hours. Next update: 4:07 AM
Data refreshes hourly during market hours. Next update: 4:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MDXG Research Pages
